Is this a consulting service?

No, this is a free, interactive software tool that calculates your potential liability under the DPDP Act 2023 in 30 seconds. It provides an instant risk score and automated action plan.

What are common DPDP violations in Pharma Data Compliance in Mumbai?

Common violations include: Collecting patient health data (e.g., medical history, drug allergies) via forms or apps without explicit, granular consent for each purpose., Sharing anonymised or de-identified patient data with research partners or marketing agencies without ensuring proper re-identification safeguards and contractual obligations., Storing electronic health records (EHRs) on servers without strong encryption, multi-factor access controls, or regular security audits, making them vulnerable to breaches..

The DPDP Audit Tool

Compliance for Pharma Data Compliance in Mumbai

💊

Pharma Data Compliance in Mumbai
Liability Check

For Mumbai's pharmaceutical giants and growing biotechs, processing patient data without explicit consent is a ₹250 Crore penalty waiting to happen. Your R&D, clinical trials, and patient management systems are all under the DPDP scanner.

Why Pharma Data Compliance in Mumbai is at Risk

Mumbai's pharmaceutical sector, from its Bandra Kurla Complex HQs to manufacturing units in Thane-Belapur, handles some of the most sensitive personal data: **patient health records, clinical trial results, genetic information, and prescription data**. The DPDP Act classifies this as 'sensitive personal data' requiring a higher standard of protection and **explicit, informed consent**. Any breach, or even improper processing, could lead to catastrophic fines, license suspension, and irreparable reputational damage, especially given the public trust inherent in healthcare. The Data Protection Board will scrutinize data flows from clinics to labs, and from pharmacies to central databases, looking for robust security and verifiable consent mechanisms.

Common Violations

1.Collecting patient health data (e.g., medical history, drug allergies) via forms or apps without explicit, granular consent for each purpose.
2.Sharing anonymised or de-identified patient data with research partners or marketing agencies without ensuring proper re-identification safeguards and contractual obligations.
3.Storing electronic health records (EHRs) on servers without strong encryption, multi-factor access controls, or regular security audits, making them vulnerable to breaches.

The Immediate Fix

Conduct a comprehensive data audit of all patient-related data flows within your Mumbai operations, identifying where sensitive health data is collected, stored, processed, and shared. Prioritise implementing a robust consent management system specifically for health data, ensuring it's auditable and purpose-specific.